Robert M. Niven

Manchester, ENG M239LT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitisation.

Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitisation.

Journal: Mucosal immunology

Published: June 25, 2025

Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma.

Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma.

Journal: The World Allergy Organization journal

Published: May 16, 2022

Bronchial Thermoplasty Global Registry (BTGR): 2-year results.

Bronchial Thermoplasty Global Registry (BTGR): 2-year results.

Journal: BMJ open

Published: December 17, 2021

Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthma.

Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthma.

Journal: BMJ open respiratory research

Published: July 16, 2021

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.

Journal: The European respiratory journal

Published: March 15, 2021

Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma.

Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 09, 2020

Same-day repeatability of fractional exhaled nitric oxide in severe asthma.

Same-day repeatability of fractional exhaled nitric oxide in severe asthma.

Journal: The European respiratory journal

Published: September 04, 2020

Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.

Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.

Journal: The Lancet. Respiratory medicine

Published: August 04, 2020

Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry.

Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry.

Journal: The journal of allergy and clinical immunology. In practice

Published: July 22, 2020

Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with cardiopulmonary magnetic resonance.

Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with cardiopulmonary magnetic resonance.

Journal: The international journal of cardiovascular imaging

Published: June 04, 2020

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.

Journal: Thorax

Published: April 29, 2020

Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma.

Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma.

Journal: BMC pulmonary medicine

Published: April 20, 2020

Showing 1-12 of 59

Last Updated: 09/26/2026